Understanding DOC2GP: A Potential Drug Target Or Biomarker (G390213)

Target Name: DOC2GP

NCBI ID: G390213

DOC2GP

Other Name(s): Double C2 domain gamma, pseudogene | double C2 domain gamma, pseudogene

Understanding DOC2GP: A Potential Drug Target Or Biomarker

The Double C2 domain gamma (DOC2GP) gene is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. DOC2GP is a member of the C2G gene family, which includes several known proteins that play important roles in various cellular processes. The most well-studied member of this family is DOC2GP-containing RNA-protein interactions, which have been shown to play a role in the regulation of gene expression.

DOC2GP is a small RNA molecule that contains 21 amino acid residues. It is expressed in a variety of tissues and cells, including brain, heart, and muscle. DOC2GP is also known as D2C2, and it is a pseudogene, which means that it does not encode a functional protein but instead serves as a carrier gene for the production of a protein known as DOC2GP-containing RNA-protein interactions (RISC).

The RISC protein is a type of RNA-protein interaction protein that plays a critical role in the regulation of gene expression. RISC proteins are composed of a nucleotide-binding oligomerization (NBO) domain, which is responsible for binding to specific DNA sequences, and a C2G domain, which is responsible for the formation of RNA-protein interactions.

Several studies have shown that DOC2GP and its RISC protein are involved in the regulation of gene expression in various organisms. For example, DOC2GP has been shown to play a role in the regulation of gene expression in Drosa, a plant species that is known for its sensitivity to environmental stress. Additionally, DOC2GP has been shown to be involved in the regulation of gene expression in Caenorhabditis elegans, a nematode species that is well-known for its ability to respond to environmental stimuli.

DOC2GP has also been shown to be involved in the regulation of gene expression in mammalian cells. For example, DOC2GP has been shown to play a role in the regulation of gene expression in human breast cancer cells. Additionally, DOC2GP has been shown to be involved in the regulation of gene expression in neuroblastoma cells, which are a type of cancer that arises from the neural stem cells that give rise to all tissues of the body.

Despite the potential drug target or biomarker implications of DOC2GP, there is currently little information about the structure and function of the protein. The only known structure of DOC2GP is a 21-amino acid residue RNA molecule that contains a single intron and a single exon at its 5' end.

In conclusion, DOC2GP is a small RNA molecule that has been identified as a potential drug target or biomarker. Its structure and function remain poorly understood, and further research is needed to determine its role in the regulation of gene expression and its potential as a drug target.

Protein Name: Double C2 Domain Gamma, Pseudogene

The "DOC2GP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DOC2GP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets